U.S. cancer diagnostic firm Caris raises IPO price range
U.S. cancer diagnostic firm Caris raises IPO price rangeSource: Investing.com
U.S. cancer diagnostic firm Caris raises IPO price rangeSource: Investing.com
Putin and Erdogan urge diplomatic resolution of Israel-Iran conflictSource: Investing.com
Caris Life Sciences Raises Price Range of 23.53M Share IPO at $19-$20/shSource: Investing.com
TSX futures inch higher amid ongoing Israel-Iran tensionsSource: Investing.com
European domestic shares seen outperforming: JPM’s MatejkaSource: Investing.com
UBS downgrades ISS to “neutral” on valuation concerns, raises target to DKr185Source: Investing.com
U.S. EPA to stop enforcement against fossil fuel companies, says CNNSource: Investing.com
Morgan Stanley weighs in on news Orange may acquire remaining 50% stake in MasOrange SpainSource: Investing.com
UBS downgrades Swissquote to “sell’ on slowing trading and crypto activitySource: Investing.com
TFG stock rises after hunter point capital agrees to acquire stake in equitixSource: Investing.com